Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1600 1613 1614 1625
This examiner grants 22% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17640253 | NOVEL COMPOSITIONS | Final Rejection | DSM IP ASSETS B.V. |
| 17642595 | PREMIX AND COMPOSITION AND METHODS OF PREPARING THE SAME | Non-Final OA | Conopco, Inc., d/b/a UNILEVER |
| 18668135 | COMPOUNDS AND FORMS OF TREATMENT FOR FEMALE SEXUAL DISORDERS | Non-Final OA | GTO Pharma, LLC. |
| 18617328 | HYPOCHLOROUS ACID-BASED DRY EYE FORMULATIONS | Non-Final OA | OCuSOFT, Inc. |
| 18021523 | SPERMIDINE AND USES THEREOF | Final Rejection | TLL THE LONGEVITY LABS GMBH |
| 18014157 | COMPOUND AS BRAIN-PERMEABLE BTK OR HER2 INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF | Non-Final OA | SHENZHEN HYPERWAY PHARMACEUTICALS CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy